GIP and diabetes mellitus: Although body mass index was a strong predictor (AUC = 0.799), adding anti-GIP Ab levels modestly improved model performance (AUC = 0.819).<h4>Conclusions</h4>Elevated baseline anti-GIP Ab levels were associated with the future development of diabetes-range glycemia and provided complementary predictive information beyond conventional metabolic risk factors.